Action for Children Zambia’s Mama Carol on CBS WCCO TV
Action for Children Zambia’s Mama Carol on CBS WCCO TV – AFCZ, is a non-profit, non-governmental organization dedicated to addressing the needs of vulnerable and displaced children in Zambia and children who need help. More information can be found at www.AFCZambia.org This story aired on Channel 4 Friday, April 15th, the day after a reception was held in Minneapolis to recognize Mama Carol’s work. AFCZ is a registered organization (ORS/102/35/3017) under Section 7 of the Societies Act of the Republic of Zambia. The primary aim of AFCZ is to provide a multi-faceted approach to combating HIV/AIDS, literacy, child abuse, child drug through drug treatment and homelessness among displaced youth, through the effective use of our In Loco Parenti approach. AFCZ’s programs for children in need, orphans, vulnerable, and displaced youth are geared to identify and address the immediate needs for each youth in crisis. AFCZ defines a crisis situation as a situation which requires immediate assistance yet, due to a child’s circumstances, remains unaddressed. Such a situation can be in the form of drug addition, illness, malnutrition, psychosocial trauma, or abandonment. Without addressing a child’s crisis situation, one cannot effectively address the child’s infection or vulnerability to HIV/AIDS. More information can be found at www.AFCZambia.org
Biovest to Seek Marketing Approval in the EU for BiovaxID(R) Personalized …
Filed under: Drug Treatment Help Minneapolis
MINNEAPOLIS, May 14, 2012 (BUSINESS WIRE) — Biovest International, Inc. (otcqb:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (otcqb:ABPI), today announced that Biovest plans to file for marketing approval in the European …
Read more on MarketWatch (press release)
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving …
Filed under: Drug Treatment Help Minneapolis
Last month, the US Food & Drug Administration (FDA) approval expanded the indication for Medtronic's CRT-D devices to treat NYHA Class II heart failure patients with a left ventricular ejection fraction (LVEF) of less than or equal to 30 percent, …
Read more on MarketWatch (press release)
Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
Filed under: Drug Treatment Help Minneapolis
RESOLUTE All Comers used the primary endpoint preferred by the US Food and Drug Administration (FDA) for studies of drug-eluting stents: target lesion failure (TLF), a composite of cardiac death, target vessel myocardial infarction and …
Read more on EON: Enhanced Online News (press release)